bioRxiv · 10.1101/2025.01.20.633961
Deep Modeling of Gain of Function Mutations on Androgen Receptor
Abstract
The efficiency of Androgen Receptor (AR) pathway inhibitors for prostate cancer (PCa) is on decline due to resistance mechanisms including the occurrence of gain-of-function mutations on human androgen receptor (AR). Hence, understanding and predicting such mutations is crucial for developing effective PCa treatment strategies. Leveraging accumulated data on clinically relevant AR mutants with recent advances in deep modeling techniques, this study aims to unveil and quantify critical AR mutation-drug relationships. By incorporating molecular descriptors for drugs and mutated genes sequences, this work represented these features as single vectors and demonstrates their effectiveness in modeling AR mutant responses to conventional antiandrogens. The developed approach achieves up to 80% accuracy in predicting the gain-of-function behavior of AR mutants and therefore can potentially uncover unknown agonist/antagonist relationships among mutant-drug pairs.
Source connections
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
You, J., Foo, J., Lallous, N., Cherkasov, A.. 2025-01-24. Deep Modeling of Gain of Function Mutations on Androgen Receptor. https://doi.org/10.1101/2025.01.20.633961
Cite the original work for its findings. Save a collection to share your selection of sources.